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GLP-1/GLP-1R Signaling in Regulation of

Introduction
Obesity, characterized by over accumulation of adipose tissue, is becoming a major health problem worldwide [1] . A body of evidence shows that obesity is closely associated with or without LG at different concentrations along with cell differentiation until day 10, then harvest cells for western blotting. For FASN detection, when cells full differentiated, adipocytes were serum-starved in DMEM containing 0.5% BSA overnight before stimulation. Then, for dose-response of liraglutide (LG) on FASN, 3T3-L1 differentiated adipocytes were stimulated with LG at different concentration (0, 1, 10, 100, 1000nM) for 24 hours. For time effect analysis, mature adipocytes were treated by LG (100nM) for various lengths of time (0, 6, 12, 24, 48 h). When indicated, adipocytes were pretreated with 10nM exendin (9-39), 20μM H89 or 20μM PD98059 or vehicle for 1 hour before stimulation with 100nM LG for 24 hours.
Animals studies
Six-week old male ob/ob mice were purchased from the Beijing HFK Bioscience CO.,LTD. Animals were cared for in accordance with "Principles of Laboratory Animal Care" established by the National Institutes of Health and animal experiments were approved by the "Animal Care and Use Committee" at Shandong University. Mice were housed in laboratory cages in a temperature-controlled room under a 12 hr lightdark cycle with free access to water and high-fat diet (HFD) containing 20% fat [37] [38] [39] . Fasting blood was detected weekly using a glucometer after 7 h of fasting at 14:00 pm with food withdrawn at 7:00 am until all mice were hyperglycemic. Then, mice were divided into 2 groups randomly, and injected subcutaneously in the abdominal region with saline (NS) or LG (300ug/kg) daily for 4 weeks. Body weight was measured daily before injection during experiments. Fasting blood was measured at the onset and termination of the study. The animals were sacrificed after deep anesthesia with ether. Immediately prior to sacrifice, blood was collected to 2ml eppendorf tube through the removable eyeball and placed at room temperature for 1 hour, then centrifuged at 3000rpm for 10 min at 4℃. The obtained plasma was snap frozen in liquid nitrogen and stored at -80℃, then sent to department of laboratory medicine of Shandong Provincial Qianfoshan Hospital affiliated to Shandong University to measure serum blood glucose, triglyceride (TG), cholesterol (CHO), low-density lipoprotein-C (LDL-C) and free fatty acids (FFA). Visceral adipose tissues obtained for RNA and protein extraction were quick frozen in liquid nitrogen and stored at -80℃. Tissues for immunohistochemistry (IHC) and immunofluorescence (IF) were immediately fixed in 4% paraformaldehyde and then sent to Wuhan Goodbio Technology CO., LTD to embed, slice and stain. Paraffin sections for IHC were stained with HE, and frozen sections for IF were stained with anti-FASN or rabbit IgG antibodies using standard protocols.
RNA extraction and real-time PCR
Total RNA isolation from cultured cells and animal adipose tissue, reverse transcription PCR and quantitative real-time PCR (qPCR) were conducted as previously described. Relative gene expression was calculated by the 2-ΔΔ Cq method [18, 40] . All measurements were performed at least for three times. qPCR primers were as follows:
18S rRNA-F: CGCGGTTCTATTTTGTTGGT; 18S rRNA-R: AGTCGGCATCGTTTATGGTC; FABP4-F: AAGGTGAAGAGCATCATAACCCT; FABP4-R: TCACGCCTTTCATAACACATTCC; PPARγ-F: TGGTGACTTTATGGAGCCTAA; PPARγ-R: GGCGAACAGCTGAGAGGACTCTG; GLP1R-F: TGCAACCGGACCTTTGATGA; GLP1R-R: TTGTAGCACACTACTGGCCC; ATGL-F: TCCGTGGCTGTCTACTAAAGA; ATGL-R: TGGGATATGATGACGTTCTCTCC; FASN-F: GGAGGTGGTGATAGCCGGTAT; FASN-R: TGGGTAATCCATAGAGCCCAG.
Western Blotting
After drug treatment, cells were washed by cold PBS containing sodium vanadate and harvested for protein extraction. Cells and about 100mg animal visceral adipose tissue were lysed in RIPA buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1% tritonX-100, 1% sodium deoxycholate, 0.1% SDS, Beyotime Biotechnology) containing protease and phosphatase inhibitors, and the protein concentration was measured using the BCA Protein Assay Kit (Sangon Biotech). Samples were subjected to electrophoresis (SDS-PAGE) with equal
Results
LG promoted 3T3-L1 preadipocytes differentiation GLP-1R was shown to be expressed in many tissues including the adipose tissue [41, 42] . In this study, we first examined the expression profile of GLP-1R during 3T3-L1 preadipocyte differentiation with PPARγ and FABP4 as differentiation makers. Adipocyte differentiation was also evaluated by oil-red O staining (Fig. 1A ). In accordance with previous results, we confirmed that GLP-1R was expressed both in preadipocytes and mature adipocytes. Interestingly, GLP-1R expression in mRNA level was decreased along with the differentiation (Fig. 1B) , while the protein expression of GLP-1R increased in the early stage of differentiation and then decreased eventually (Fig. 1C , D, E, F). To determine the role of GLP-1 in adipocyte differentiation, 3T3-L1 preadipocytes were induced with MDI (Dexamethasone, IBMX, insulin) induction medium in the absence or presence of liraglutide (LG), a GLP-1 receptor agonist. Results showed that LG enhanced PPARγ and FABP4 expression and increased lipid accumulation in a dose-dependent manner ( Fig. 2A and B) . 
LG reduced FASN expression via GLP-1R in mature adipocytes
To explore the role of LG in lipid metabolism in mature adipocytes, we examined its effect on the expression of FASN, a key enzyme in the de novo lipogenesis, and ATGL, an enzyme for lipolysis. Differentiated 3T3-L1 adipocytes were treated with LG as indicated. As is shown, LG treatment significantly reduced FASN expression in both mRNA and protein levels in dose-and time course dependent manners (Fig. 2C, D , F and G), whereas LG showed no obvious effect on ATGL expression (Fig. 2C, E and G) . In order to investigate whether the effect of LG was mediated by GLP-1R, we pretreated adipocytes with exendin (9-39), a specific blocker for GLP-1R. As expected, LG-induced FASN downregulation was attenuated by exendin (Fig. 2H) .
LG reduced FASN expression in adipocytes through activation of PKA and MAPK To determine the downstream signaling pathways that may mediate the effect of LG, we examined its effects on activation of pCREB and ERK, both have been implicated in adipocytic differentiation and lipid metabolism. As shown in Figure 2C and G, LG treatment induced CREB and ERK phosphorylation in dose-dependent manner and time-dependent manners.
To further explore whether LG reduced FASN expression in adipocytes through activation of PKA and MAPK, we conducted additional experiments using specific inhibitors for PKA and ERK. As shown in Fig. 3A, H89 , a specific inhibitor for PKA, prevented LG induced FASN down-regulation and CREB activation, relative protein expression were shown in Fig. 3B . PD98059, a specific ERK inhibitor, blocked ERK phosphorylation and significantly prevented LG induced-FASN down-regulation ( Fig. 3D and E) . However, no obvious changes were observed in lipid droplets measured by oil red O staining ( Fig. 3C and F) .
LG treatment prevented mice body weight gain and adiposity After 4 weeks, LG treated mice showed less weight gain when compared to control mice injected with saline ( Fig. 4A ) (7.47 ± 0.52 vs. 2.9 ± 1.25 g, P < 0.05). The body weight gain showed no difference in the first 3 weeks between the two groups until the 4 th week (Fig.  4B) . Meanwhile, the visceral fat weight and the ratio of visceral fat weight to body weight were also markedly decreased in LG injection mice when compared to control mice ( Fig. 4C  and D) . In addition, the average size of adipocytes in the perirenal and epididymal adipose 
Discussion
Obesity, a condition of body characterized by over accumulation of fat, is associated with multiple metabolic disorders, including dyslipidemia, hyperinsulinemia and impaired glucose metabolism. Obese patients often accompanied by decreased vascular flexibility, increased blood lipids and reduced insulin sensitivity. These disorders contribute to the development of diabetes mellitus, hypertension and cardiovascular disease [3, 5, 8, 11] . According to the viewpoint of energy balance, obesity develops when energy intake by an individual exceeds the rate of energy expenditure. At cellular level, obesity can be considered as a hypertrophic disease resulted from an increase in the number or size of individual adipocyte. The number of adipocytes in adults is usually invariable, therefore, adult obesity often present as the increase of adipocytes size, that is, adipogenesis.
GLP-1, an incretin hormone, is predominantly produced by L cells of the distal small intestine in response to food intake [25] . It is generally believed that the action of GLP-1 is mediated by its specific receptor (GLP-1R). GLP-1R is showed to be expressed in many tissues, including pancreas, GI system, heart, liver, kidney, muscle, adipose tissue as well as the central and peripheral nervous systems [41, 42] . To explore the possible roles of GLP-1/ GLP-1R in adipogenesis and lipid metabolism, we first examined the expression profile of GLP-1R in 3T3-L1 adipocytes. Consistent with previous observations [43, 44] , we confirmed the presence of GLP-1R in both preadipocytes and differentiated adipocytes. Interestingly, we found that GLP-1R expression in both mRNA and protein levels decrease along with the differentiation, which may imply that GLP-1/GLP-1R signaling could play more important roles in undifferentiated adipocytes.
Next, we determined whether GLP-1 has direct effect on adopocyte differentiaton. Previous studies have revealed that adipogenesis process is orchestrated by numerous moleculars, including the products of adipocyte-specific genes C/EBPs and PPARγ. [45, 46] These transcription factors are the primary drivers of differentiation [47] . Liraglutide (LG) is a GLP-1 analog with 97% amino-acid sequence homology to native GLP-1. In this study, we demonstrated that LG treatment significantly promoted 3T3-L1 preadipocyte differentiation in a dose dependent manner as evidenced by increased PPARγ and FABP4 expression and lipid accumulation. Further experiments showed that these effects of LG were abolished by specific GLP-1 receptor blocker, suggesting that these effects of LG are mediated by GLP-1 receptor. Our results are generally consistent with previous studies . However, there is a study showing that GLP-1 promoted the proliferation of human bone marrow-derived mesenchymal stem cells (hMSCs), while prevented the differentiation of these cells into adipocytic lineage [48] . It is possible that GLP-1 may have distinct effects in different stages of adipocyte differentiation and maturation. Recent studies showed that obese individuals have reduced differentiation capability of their preadipocytes, or so-called "impaired adipose tissue expandability", which may contribute to metabolic complications and insulin resistance due to ectopic deposition of excess lipid in non-adipose tissues like skeletal muscle or liver [49] [50] [51] . From this viewpoint, our findings may partially explain the beneficial effects of GLP-1 on insulin resistance and non-alcoholic fatty liver disease.
To determine the role of GLP-1 in lipid metabolism in mature adipocytes, we examined the effects of LG on the expression of FASN and ATGL. FASN is the key enzyme in the de novo lipogenesis, whereas ATGL is an important enzyme for lipolysis. In consistency with previous studies [11, 41, 52, 53] , we found that LG treatment significantly reduced FASN expression in both protein and mRNA levels, but had on obvious effect on ATGL expression. Additional experiments showed that LG-induced down-regulation of FASN was accompanied with increased phosphorylation of pCREB and ERK, and specific inhibitors for PKA and ERK partially prevented LG induced FASN down-regulation. These findings indicate that GLP-1 negatively regulates FASN expression, which is at least partially mediated by PKA and MAPK pathways.
To substantiate our findings in vitro, we further conducted animal experiments with six-week old male ob/ob mice. Consistent with previous studies [33] [34] [35] , our results showed that LG treatment significantly decreased the weight gain of ob/ob mice after 4 weeks. Meanwhile, the visceral fat weight and the ratio of visceral fat weight to body weight were also markedly decreased in LG treated mice when compared to controls. Furthermore, the average size of adipocytes in visceral adipose tissues was markedly smaller in LG treated mice. We examined FASN expression in the perirenal and epididymal adipose tissues of ob/ ob mice. Consistent with our findings in cell experiments, LG treatment significantly reduced FASN expression in both mRNA and protein levels. We suppose that the reduced hypertrophy of adipocytes in LG treated mice may be partially due to the inhibition of FASN expression, which may also partially account for the reduced visceral fat weight.
As we found, there was no change in the expression of ATGL in vitro experiments. Thus, we did not check its expression in vivo study.
Taken together, in this study we demonstrated that GLP-1 can directly promote preadipocyte differentiation via a GLP-1 receptor dependent mechanism. In addition, GLP-1 may inhibit lipogenesis in mature adipocytes by down-regulating FASN expression, which is at least partially mediated by PKA and MAPK pathways. Our findings reveal a direct link between GLP-l, obesity and obesity related dyslipidemia.
